# Onset of Action of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray Compared With Placebo in Seasonal Allergic Rhinitis (C93-184)

> **NCT03861559** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 201 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal

## Interventions

- **DRUG:** mometasone furoate nasal spray
- **DRUG:** placebo nasal spray

## Key facts

- **NCT ID:** NCT03861559
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-03-30
- **Primary completion:** 1994-06-27
- **Final completion:** 1994-07-07
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03861559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03861559, "Onset of Action of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray Compared With Placebo in Seasonal Allergic Rhinitis (C93-184)". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03861559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*